Filing Details

Accession Number:
0001455244-12-000063
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-05 13:51:52
Reporting Period:
2012-11-01
Filing Date:
2012-11-05
Accepted Time:
2012-11-05 13:51:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Qlt Inc QLTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1369220 R Alexander Lussow C/O Qlt Inc.
887 Great Northern Way, Suite 101
Vancouver A1 V5T 4T5
Sr. Vp, Bus. Dev. & Comm. Op. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-01 5,000 $3.74 25,000 No 4 M Direct
Common Stock Disposition 2012-11-01 5,000 $7.52 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2012-11-01 5,000 $0.00 5,000 $3.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,000 2013-05-17 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. Price reflects the conversion of Canadian dollars to US dollars based on the exchange rate in effect as of the date of the reportable event.
  3. The option vested in 36 equal monthly installments, beginning on June 17, 2008.